Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.

Spitzer WO.

J Obstet Gynaecol Can. 2004 Jun;26(6):549-50. No abstract available.

PMID:
15762006
2.
3.

Commentary: Blaxill, Baskin, and Spitzer on Croen et al. (2002), the changing prevalence of autism in California.

Blaxill MF, Baskin DS, Spitzer WO.

J Autism Dev Disord. 2003 Apr;33(2):223-6; discussion 227-9. No abstract available.

PMID:
12757365
4.

Measles, mumps, and rubella vaccination and autism.

Spitzer WO.

N Engl J Med. 2003 Mar 6;348(10):951-4; author reply 951-4. No abstract available.

PMID:
12622119
5.

The apprenticeship of an editor and the secret role of a mentor.

Spitzer WO.

J Clin Epidemiol. 2002 Dec;55(12):1173-5.

PMID:
12547444
6.

Myocardial infarction and third generation oral contraceptives: aggregation of recent studies.

Spitzer WO, Faith JM, MacRae KD.

Hum Reprod. 2002 Sep;17(9):2307-14.

PMID:
12202417
7.

The teacher's teacher: a personal tribute to Alvan R Feinstein.

Spitzer WO.

J Epidemiol Community Health. 2002 May;56(5):328-9. No abstract available.

8.

The natural history of autistic syndrome in British children exposed to MMR.

Spitzer WO, Aitken KJ, Dell'Aniello S, Davis MW.

Adverse Drug React Toxicol Rev. 2001 Aug;20(3):160-3. Review. No abstract available.

PMID:
11668865
9.

A sixty day war of words: is MMR linked to autism?

Spitzer WO.

Adverse Drug React Toxicol Rev. 2001 Mar;20(1):47-55. No abstract available.

PMID:
11395938
10.

Oral contraceptives and cardiovascular outcomes: cause or bias?

Spitzer WO.

Contraception. 2000 Aug;62(2 Suppl):3S-9S; discussion 37S-38S. Review.

PMID:
11102597
11.

Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.

Suissa S, Spitzer WO, Rainville B, Cusson J, Lewis M, Heinemann L.

Hum Reprod. 2000 Apr;15(4):817-21.

PMID:
10739826
12.

The aftermath of a pill scare: regression to reassurance.

Spitzer WO.

Hum Reprod Update. 1999 Nov-Dec;5(6):736-45. Review.

PMID:
10652982
13.

Are wireless phones safe? A review of the issue.

Masley ML, Habbick BF, Spitzer WO, Stuchly MA.

Can J Public Health. 1999 Sep-Oct;90(5):325-9. Review.

PMID:
10570577
14.

The differential risk of oral contraceptives: the impact of full exposure history.

Lewis MA, MacRae KD, Kühl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO.

Hum Reprod. 1999 Jun;14(6):1493-9.

PMID:
10359554
15.

Pharmacoepidemiology: barriers and bridges. Tribute to Irene Guggenmoos-Holzmann.

Spitzer WO.

J Clin Epidemiol. 1999 Apr;52(4):351-4. No abstract available.

PMID:
10235175
16.

Bias versus causality: interpreting recent evidence of oral contraceptive studies.

Spitzer WO.

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 2):S43-50. Review.

PMID:
9753310
17.

Thromboembolism and the pill: the saga must end.

Spitzer WO.

Hum Reprod. 1998 May;13(5):1117-8. No abstract available.

PMID:
9647524
18.

Questions on breast-implants study.

Clark P, Garbe E, Habbick B, Lawrence V, Spitzer WO.

Lancet. 1998 May 2;351(9112):1358-9. No abstract available.

PMID:
9643824
19.

Scientific problems with a noncausal artifact.

Heinemann LA, Spitzer WO, Winkler UH.

Am J Obstet Gynecol. 1998 May;178(5):1105-7. No abstract available.

PMID:
9609596
20.

Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Heinemann LA, Lewis MA, Spitzer WO, Thorogood M, Guggenmoos-Holzmann I, Bruppacher R.

Contraception. 1998 Jan;57(1):29-37.

PMID:
9554248
21.

The 1995 pill scare revisited: anatomy of a non-epidemic.

Spitzer WO.

Hum Reprod. 1997 Nov;12(11):2347-57. Review.

PMID:
9436662
22.

Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.

Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.

BMJ. 1997 Dec 6;315(7121):1502-4.

23.

Valvular heart disease associated with fenfluramine-phentermine.

Spitzer WO.

N Engl J Med. 1997 Dec 11;337(24):1774-5; author reply 1775-6. No abstract available.

PMID:
9411251
24.

Balanced view of risks of oral contraceptives.

Spitzer WO.

Lancet. 1997 Nov 29;350(9091):1566-7. Erratum in: Lancet 1998 Feb 14;351(9101):530.

PMID:
9393332
25.

First-time use of newer oral contraceptives and the risk of venous thromboembolism.

Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L.

Contraception. 1997 Sep;56(3):141-6.

PMID:
9347203
27.

Lowered risk of dying of heart attack with third generation pill may offset risk of dying of thromboembolism.

Lewis MA, Spitzer WO, Heinemann LA, MacRae KD, Bruppacher R.

BMJ. 1997 Sep 13;315(7109):679-80. No abstract available.

28.

Analysis of Centers for Disease Control and Prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population.

Spitzer WO, Haggerty JL, Berkson L, Davis W, Palmer W, Tamblyn R, Laprise R, Mulder LJ.

J Rheumatol Suppl. 1996 Oct;46:73-9; discussion 79-80.

PMID:
8895183
29.

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO.

Contraception. 1996 Jul;54(1):5-13. Erratum in: Contraception 1996 Aug;54(2):121.

PMID:
8804801
30.

The future of epidemiology.

Spitzer WO.

J Clin Epidemiol. 1996 Jul;49(7):705-9. No abstract available.

PMID:
8691218
31.

Rebuilding confidence in oral contraceptives: a new imperative in family planning.

Spitzer WO.

Br J Clin Pharmacol. 1996 May;41(5):359-63. Erratum in: Br J Clin Pharmacol 1996 Sep;42(3):406.

32.

The future of oral contraceptives: research priorities.

Spitzer WO.

Hum Reprod. 1996 Apr;11(4):688-9.

PMID:
8671299
35.

Interim review of the Transnational Case-control Study of Oral Contraceptives and Health: approved protocol revisions through September 1995.

Lewis DM, Assmann A, Heinemann L, Spitzer WO.

Pharmacoepidemiol Drug Saf. 1996 Jan;5(1):43-51.

PMID:
15088277
36.

Data from transnational study of oral contraceptives have been misused.

Spitzer WO.

BMJ. 1995 Oct 28;311(7013):1162. No abstract available.

37.

Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: redefining "whiplash" and its management.

Spitzer WO, Skovron ML, Salmi LR, Cassidy JD, Duranceau J, Suissa S, Zeiss E.

Spine (Phila Pa 1976). 1995 Apr 15;20(8 Suppl):1S-73S. Review. No abstract available. Erratum in: Spine 1995 Nov 1;20(21):2372.

PMID:
7604354
38.

Continuing occurrence of eosinophilia myalgia syndrome in Canada.

Spitzer WO, Haggerty JL, Berkson L, Davis W, Palmer W, Tamblyn R, Laprise R, Faith JM, Elmore JG, Horwitz RI.

Br J Rheumatol. 1995 Mar;34(3):246-51.

PMID:
7728400
39.

Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis.

Cook DJ, Sackett DL, Spitzer WO.

J Clin Epidemiol. 1995 Jan;48(1):167-71. Review. No abstract available.

PMID:
7853043
40.

The challenge of meta-analysis.

Spitzer WO.

J Clin Epidemiol. 1995 Jan;48(1):1-4. No abstract available.

PMID:
7853036
41.

Outmigrant ascertainment for bias assessment in environmental epidemiology.

Tousignant P, Groome PA, Spitzer WO, Schechter MT, Montano L, Hutcheon ME.

Int J Epidemiol. 1994 Oct;23(5):1091-8.

PMID:
7860161
42.

Is peer-reviewing fair?

Spitzer WO.

J Clin Epidemiol. 1994 Jul;47(7):819-20. No abstract available.

PMID:
7722596
43.

Beta-agonist use and death from asthma.

Suissa S, Ernst P, Spitzer WO.

JAMA. 1994 Mar 16;271(11):821-2. No abstract available.

PMID:
7906743
44.

A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, Blais L, McNutt M, Buist AS, Spitzer WO.

Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):604-10.

PMID:
8118625
45.

Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

Ernst P, Habbick B, Suissa S, Hemmelgarn B, Cockcroft D, Buist AS, Horwitz RI, McNutt M, Spitzer WO.

Am Rev Respir Dis. 1993 Jul;148(1):75-9.

PMID:
8100409
46.

Low back pain in the workplace: attainable benefits not attained.

Spitzer WO.

Br J Ind Med. 1993 May;50(5):385-8. No abstract available.

47.

Beta-agonists and asthma research: an international consultation.

Ernst P, Spitzer WO, Suissa S, Cockroft DW, Buist AS.

Eur Respir J. 1993 Feb;6(2):273-8. No abstract available.

PMID:
8095241
48.

Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use.

Ernst P, Spitzer WO, Suissa S, Cockcroft D, Habbick B, Horwitz RI, Boivin JF, McNutt M, Buist AS.

JAMA. 1992 Dec 23-30;268(24):3462-4.

PMID:
1460737
49.

Effect of negative pressure ventilation in severe chronic obstructive pulmonary disease.

Shapiro SH, Ernst P, Gray-Donald K, Martin JG, Wood-Dauphinee S, Beaupré A, Spitzer WO, Macklem PT.

Lancet. 1992 Dec 12;340(8833):1425-9.

PMID:
1360558
50.

Fenoterol and death from asthma.

Spitzer WO, Ernst P, Suissa S, Boivin JF, Horwitz RI, Habbick B, Cockcroft D, McNutt M, Buist AS.

Med J Aust. 1992 Oct 19;157(8):567-8. No abstract available.

PMID:
1479985

Supplemental Content

Loading ...
Support Center